JAK1/STAT3-IN-1
JAK1/STAT3-IN-1 (compound 4f) is an anti-AD (atopic dermatitis) agent by inhibiting JAK1/STAT3 signaling pathway. JAK1/STAT3-IN-1 inhibits NO generation with an IC50 of 2.17 μM. JAK1/STAT3-IN-1 improves the skin condition of AD-like mice, reduces inflammatory infiltration, inhibits the expressions of p-JAK1/JAK1 and p-STAT3/STAT3, and mitigates the excessive immune response on Calcipotriol (MC903) -induced AD-like mice[1].
Product Specifications
UNSPSC
12352005
Target
JAK; STAT
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
O=C(/C=C/C1=CC=C(N2CCN(C)CC2)C=C1)C3=CC=C(N4CCN(S(C5=CC=C(F)C=C5)(=O)=O)CC4)C=C3
Molecular Formula
C30H33FN4O3S
Molecular Weight
548.67
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
JAK1; STAT3
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PDCD1 / PD1 / CD279 (Programmed Cell Death 1) (NAT105), 1mg/mL
MART-1 / Melan-A (M2-7C10 + M2-9E3), CF488A conjugate, 0.1mg/mL
